Lai Corporation Pty. Ltd. Report issue

For profit Phase 1
Founded: Perth Australia (2018)

Organization Overview

First Clinical Trial
2019
NCT03825146
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Lai Corporation Pty. Ltd.